Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
1.340
-0.010 (-0.74%)
Feb 21, 2025, 4:00 PM EST - Market closed
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $1.93 million as of February 21, 2025. Its market cap has decreased by -12.22% in one year.
Market Cap
1.93M
Enterprise Value
-1.02M
1-Year Change
-12.22%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.40M to $1.93M, a decrease of -99.24%. That is a compound annual growth rate of -38.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.90M | -29.63% |
| Dec 31, 2024 | 2.70M | 3.85% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.43% |
| Dec 29, 2017 | 62.70M | -33.93% |
| Dec 30, 2016 | 94.90M | -57.52% |
| Dec 31, 2015 | 223.40M | -12.19% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |